Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a prospective, randomized, open label, parallel,4-month study to explore and evaluate the therapeutic effects of polyethylene glycol loxenatide on the cognitive function, olfactory function, and odor-induced brain activation in T2DM patients with normal cognitive status or MCI.
Epistemonikos ID: 6a26b0642df9ba9515a77b70eaac8a00e16bce1c
First added on: May 15, 2024